OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The complex genetic architecture of Alzheimer's disease: novel insights and future directions
Shea J. Andrews, Alan E. Renton, Brian Fulton‐Howard, et al.
EBioMedicine (2023) Vol. 90, pp. 104511-104511
Open Access | Times Cited: 187

Showing 1-25 of 187 citing articles:

Recent advances in Alzheimer’s disease: Mechanisms, clinical trials and new drug development strategies
Jifa Zhang, Yinglu Zhang, Jiaxing Wang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 135

Mitochondrial Dynamics in Neurodegenerative Diseases: Unraveling the Role of Fusion and Fission Processes
Hubert Grel, Damian Woźnica, Katarzyna Ratajczak, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13033-13033
Open Access | Times Cited: 42

Innate immune activation in neurodegenerative diseases
Sergio Castro‐Gomez, Michael T. Heneka
Immunity (2024) Vol. 57, Iss. 4, pp. 790-814
Closed Access | Times Cited: 21

Immune Activation in Alzheimer Disease
Arnaud Mary, Renzo Mancuso, Michael T. Heneka
Annual Review of Immunology (2024) Vol. 42, Iss. 1, pp. 585-613
Closed Access | Times Cited: 19

Microglia and amyloid plaque formation in Alzheimer's disease – Evidence, possible mechanisms, and future challenges
Stefanie Fruhwürth, Henrik Zetterberg, Søren R. Paludan
Journal of Neuroimmunology (2024) Vol. 390, pp. 578342-578342
Open Access | Times Cited: 19

Neuroinflammation in Alzheimer disease
Wiesje M. van der Flier, Wiesje M. van der Flier, Frank Jessen, et al.
Nature reviews. Immunology (2024)
Closed Access | Times Cited: 18

Comprehensive characterization of the transcriptional landscape in Alzheimer’s disease (AD) brains
Chengxuan Chen, Zhao Zhang, Yuan Liu, et al.
Science Advances (2025) Vol. 11, Iss. 1
Open Access | Times Cited: 2

Artificial intelligence for drug discovery and development in Alzheimer's disease
Yunguang Qiu, Feixiong Cheng
Current Opinion in Structural Biology (2024) Vol. 85, pp. 102776-102776
Open Access | Times Cited: 14

Genetic forms of tauopathies: inherited causes and implications of Alzheimer’s disease-like TAU pathology in primary and secondary tauopathies
Felix Langerscheidt, Tamara Wied, Mohamed Aghyad Al Kabbani, et al.
Journal of Neurology (2024) Vol. 271, Iss. 6, pp. 2992-3018
Open Access | Times Cited: 13

Brain responses to intermittent fasting and the healthy living diet in older adults
Dimitrios Kapogiannis, Apostolos Manolopoulos, Roger J. Mullins, et al.
Cell Metabolism (2024) Vol. 36, Iss. 8, pp. 1668-1678.e5
Closed Access | Times Cited: 13

Unraveling the Genetic Landscape of Neurological Disorders: Insights into Pathogenesis, Techniques for Variant Identification, and Therapeutic Approaches
Zeba Firdaus, Xiaogang Li
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2320-2320
Open Access | Times Cited: 11

Genetically transitional disease: conceptual understanding and applicability to rheumatic disease
Timothy B. Niewold, Ivona Aksentijevich, Peter D. Gorevic, et al.
Nature Reviews Rheumatology (2024) Vol. 20, Iss. 5, pp. 301-310
Closed Access | Times Cited: 11

Role of the X Chromosome in Alzheimer Disease Genetics
Michaël E. Belloy, Yann Le Guen, Ilaria Stewart, et al.
JAMA Neurology (2024)
Closed Access | Times Cited: 11

Controversial Past, Splendid Present, Unpredictable Future: A Brief Review of Alzheimer Disease History
Félix Bermejo‐Pareja, Teodoro del Ser
Journal of Clinical Medicine (2024) Vol. 13, Iss. 2, pp. 536-536
Open Access | Times Cited: 10

Comprehensive Overview of Alzheimer’s Disease: Etiological Insights and Degradation Strategies
Manish Kumar Singh, Yoonhwa Shin, Songhyun Ju, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 6901-6901
Open Access | Times Cited: 10

The ABC's of Alzheimer risk gene ABCA7
Lena Duchateau, Nicole Wawrzyniak, Kristel Sleegers
Alzheimer s & Dementia (2024) Vol. 20, Iss. 5, pp. 3629-3648
Open Access | Times Cited: 8

Genetic, transcriptomic, histological, and biochemical analysis of progressive supranuclear palsy implicates glial activation and novel risk genes
Kurt Farrell, Jack Humphrey, Timothy S. Chang, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 8

Silver linings for the silver economy: institutional and entrepreneurial responses to healthy ageing and long-term care in India
Rakhi Rawat, S. Mukherjee, Allen Prabhaker Ugargol, et al.
Journal of Social and Economic Development (2025)
Closed Access | Times Cited: 1

Alzheimer’s Disease and Porphyromonas gingivalis: Exploring the Links
Ivana Shawkatová, Vladimı́ra Ďurmanová, Juraj Javor
Life (2025) Vol. 15, Iss. 1, pp. 96-96
Open Access | Times Cited: 1

Epigenetics in Neurodegenerative Diseases
Brigitte van Zundert, Martı́n Montecino
Sub-cellular biochemistry/Subcellular biochemistry (2025), pp. 73-109
Closed Access | Times Cited: 1

The impact of genetic variability on Alzheimer’s therapies: obstacles for pharmacogenetic progress
Ramón Cacabelos, Olaia Martínez-Iglesias, Natalia Cacabelos, et al.
Expert Opinion on Drug Metabolism & Toxicology (2025), pp. 1-28
Closed Access | Times Cited: 1

The Spectrum of Genetic Risk in Alzheimer Disease
Nicholas E. Karagas, Jessica E. Young, Elizabeth Blue, et al.
Neurology Genetics (2025) Vol. 11, Iss. 1
Closed Access | Times Cited: 1

Synapse vulnerability and resilience underlying Alzheimer’s disease
Raquel N. Taddei, Karen Duff
EBioMedicine (2025) Vol. 112, pp. 105557-105557
Open Access | Times Cited: 1

The Common Alzheimer's Disease Research Ontology (CADRO) for biomarker categorization
Amanda M. Leisgang Osse, Jefferson W. Kinney, Jeffrey L. Cummings
Alzheimer s & Dementia Translational Research & Clinical Interventions (2025) Vol. 11, Iss. 1
Open Access | Times Cited: 1

CASP8 intronic expansion identified by poly-glycine-arginine pathology increases Alzheimer’s disease risk
Lien Nguyen, Ramadan Ajredini, Shu Guo, et al.
Proceedings of the National Academy of Sciences (2025) Vol. 122, Iss. 7
Open Access | Times Cited: 1

Page 1 - Next Page

Scroll to top